The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
MEDIA ADVISORY ASCO EMBARGOED PRESSCAST THURSDAY, MAY 14
WHAT:
ASCO PRESENTS STUDIES FROM UPCOMING ANNUAL MEETING
WHO:
Eric Winer, MD, Cancer Communications Committee Chair - moderator
Richard L. Schilsky, MD, ASCO President
Douglas Blayney, MD, ASCO President-Elect
Maura Gillison, MD – study author
Masahiro Fukuoka, MD – study author
David Kerr, MD - study author
Juan Valle, MD - study author
Julie Ryan, MD - study author
Deborah Schrag, MD - study author
Alice Yu, MD - study author
WHEN:
Thursday, May 14 at 12:00 p.m. EDT
HOW: Pre-registration is required. To register, please go to www.asco.org/mediaHQ and complete the online registration form. You will have two registration options:
May 14 Presscast Only – U.S. and Non-U.S. participants who want to pre-register for just the Presscast. DEADLINE: 11:59 PM EDT Wednesday, May 13
NOTE: Tomorrow is the deadline* for U.S. journalists to pre-register for the ASCO 2009 Annual Meeting!
U.S. Onsite and Presscast – U.S. participants who want to pre-register to participate in the Presscast and the Annual Meeting in Orlando May 28 – June 2, 2009.
DEADLINE: 11:59 PM EDT Friday, May 8 *U.S. media has the option of registering on-site in Orlando
For more questions about registration contact:
Claudine McElwain 571-483-1370 or
Kelly Powell 571-483-1365
The presscast will highlight the following studies:
Large, randomized trial to test whether ginger supplements, combined with anti-nausea drugs, can reduce chemotherapy-related nausea
A study to determine the ability of a multi-gene RT-PCR assay to predict the risk of recurrence and chemotherapy response in stage II colon cancer patients
Randomized Phase III study evaluating the effect of a therapeutic cancer vaccine (chimeric anti-GD2 antibody ch14.18) in patients with high-risk neuroblastoma
A Phase III study evaluating the survival benefit associated with cisplatin in patients with advanced inoperable biliary tract cancer, a disease which has been challenging to treat
The largest study to date to examine the influence of HPV infection on survival in patients with certain head and neck cancers
Research examining EGFR mutation status and response to first-line gefitinib treatment in Asian patients with non-small cell lung cancer
A study examining how patients enrolled in clinical trials cope with prescription drug costs and the anxiety brought on by these costs
